The Global 3D Bioprinting Market Report by The Business Research Company covers 3D bioprinting market drivers and restraints, 3D bioprinting market size, major players, and the impact of COVID-19 on the 3D bioprinting market.
The 3D bioprinting market consists of sales of 3D bioprinting products by entities (organizations, sole traders, and partnerships) that are engaged in manufacturing and utilizing 3D printing to produce biomedical parts that imitate natural tissue characteristics. 3D Bioprinting is a type of additive manufacturing that prints live structures layer by layer, mimicking the behavior of actual living systems, using cells and other biocompatible materials like inks, also known as bio-inks. 3D bioprinting materials are mainly used in connection with drug research and most recently as cell scaffolds to help repair damaged ligaments and joints.
The global 3D bioprinting market is expected to grow from $771.41 million in 2020 to $933.91 million in 2021 at a compound annual growth rate (CAGR) of 21.1%. The change in growth trend of the 3D bioprinting market is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. The 3D bioprinting market is expected to reach $1,899.37 million in 2025 at a CAGR of 19.4%.
Rising governments and private funding to support 3D bioprinting research activities are expected to drive the growth of the 3D bioprinting market in the forecast period. 3D bioprinting has increasing applications in healthcare, attracting funding from government and private organizations. This funding provides financial and technical assistance across different development phases of 3D bioprinting techniques.
Request A Sample For The Global 3D Bioprinting Market Report:
Some 3D bioprinting market trends include increasingly using artificial intelligence (AI) in 3D bioprinting to fabricate bio-tissues in a layer-to-layer fashion from a digital 3D model using a combination of cells, growth factors, and biomaterials.
Global 3D bioprinting market segments include:
1) By Component: 3D Bioprinters, Bioinks
2) By Material: Living Cells, Hydrogels, Extracellular Matrices, Others
3) By Application: Research Applications, Clinical Application, Others
4) By End User: Research Organization And Academic Institutes, Biopharmaceuticals Companies, Hospitals, Others
5) By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Read More On The 3D Bioprinting Global Market Report 2021: COVID-19 Implications And Growth At:
The 3D Bioprinting Global Market Report 2021: COVID-19 Implications And Growth is one of a series of new reports from The Business Research Company that provides 3D bioprinting market overviews, analyzes and forecasts market size, share, 3D bioprinting market players, 3D bioprinting market segments and geographies, market’s leading competitors’ revenues, profiles and market shares.
The 3D bioprinting identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Where To Learn More:
Read 3D Bioprinting Global Market Report 2021: COVID-19 Implications And Growth from The Business Research Company for information on the following:
Data Segmentations: Market Size, Global, By Region And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries
Market Players Covered: Organovo Holdings Inc., Allevi Inc., Cellink, Aspect Biosystems Ltd., 3D Systems Corporation, Cyfuse Biomedical KK, Envisiontec Inc., Poietis, TeVido BioDevices, Nano3D Biosciences Inc., Digilab Inc., RegenHU, GeSIM GmbH, Advanced Solutions Life Sciences LLC, Regenovo Biotechnology Co. Ltd., Regemat 3D S.L., Bio3D Technologies, Stratasys Ltd, ROKIT Healthcare, Inventia Life Science PTY LTD, Vivax Bio LLC, GE Healthcare, and 3D Biotek.
Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)
Other Information And Analyses: SWOT analysis, customer information, market product/service analysis – product examples, trends and opportunities, drivers and restraints, key mergers and acquisitions, suggested trend based strategies, impact of COVID-19 on the market, future outlook and potential analysis, key metrics covered: number of enterprises, number of employees, global market in 2021 – countries offering most new opportunities, conclusions and recommendations by expert analysts.
Sourcing and Referencing: Data and analysis throughout the report are sourced using end notes.
Strategies For Participants In The 3D Bioprinting Industry: The report explains a number of strategies for companies in the market, based on industry trends and company analysis.
Opportunities For Companies In The 3D Bioprinting Sector: The report reveals where the global industry will put on most $ sales up to 2023.
Interested to know more about The Business Research Company?
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
Read more about us at www.thebusinessresearchcompany.com
Here is a list of reports from The Business Research Company similar to the 3D Bioprinting Global Market Report 2021:
Reach us at:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Follow us on LinkedIn: https://bit.ly/3b7850r
Follow us on Facebook: https://bit.ly/3lyGAlo
Follow us on Twitter: https://bit.ly/3b1rmjS